BioDelivery Sciences International, Inc. announced the appointment of Terry Coelho as Chief Financial Officer. Ms. Coelho brings to BDSI more than 30 years of financial and operational experience and will serve as a member of the company's executive leadership team. Most recently, Ms. Coelho served as Chief Financial Officer and Treasurer at Balchem Corporation.

Previously, she served as Chief Operating Office for Diversey, Inc. Ms. Coelho succeeds Ernie De Paolantonio who is retiring from the company as previously announced. Ms. Coelho will also serve as the Company's principal financial officer and principal accounting officer. Ms. Coelho replaced Ernest De Paolantonio in these positions effective as of January 15, 2019.

Mr. De Paolantonio will remain at the Company past such date in order to allow for an orderly transition. Prior to joining the Company, Ms. Coelho, 57, served as the Chief Financial Officer & Treasurer for Balchem Corporation from October 2017 to October 2018. Prior to that, Ms. Coelho served as Chief Operating Officer of Diversey, Inc. from September 2017 to October 2017.

Prior to that role, Ms. Coelho served as Vice President Finance and Global Commercial Excellence for Diversey Care, a division of Sealed Air Corporation, from February 2016 to August 2017 and Vice President Finance for Diversey Care from October 2014 to February 2016. Prior to joining Diversey Care, Ms. Coelho served as the Global Head of Oncology Development Finance for Novartis Pharmaceuticals Corporation, a multinational pharmaceutical company, from March 2010 to October 2014. Ms. Coelho has also held numerous roles of increasing responsibility with Novartis from 2007 through 2014 and with Mars Inc., a global manufacturer of confectionery, pet food and other food products, from 1987 to 2007.

Ms. Coelho holds an M.B.A. in Finance from IBMEC in Brazil, and a B.A. in both Economics and International Relations, summa cum laude, from The American University School of International Service, in Washington, DC.